Pediatrics

RegulatoryJune 29, 2026

GE HealthCare Issues Correction for Infant Resuscitation Systems Due to Oxygen Concentration Risk

GE HealthCare has issued a correction for Giraffe and Panda infant resuscitation systems due to a potential loosening of the air-oxygen blender knob shaft, which may affect oxygen delivery.

Companies

Assets

Recent signals(15)

FDA Accepts Supplement Application for Children's Advil-Flavored

Study on NIRS for Early Diagnosis of NEC in Neonates

BioMarin's Study on Growth in Children with Idiopathic Short Stature Underway

CPAP Trial Aims to Reduce Bronchopulmonary Dysplasia in Premature Infants

Machine Learning Study Aims to Diagnose Cholestasis in Newborns Using Parent-Provided Images

FDA Approval Update for Children's Advil (Ibuprofen) by Haleon

FDA Approval for Children's Advil-Flavored Supplement by Haleon

Study on Integrating Behavioral Therapy in Primary Care for ADHD in Underserved Children

Study Compares Tracheoscopy Techniques in Neonates With Tracheoesophageal Fistula

Study on ABI Detection in Pediatric ECMO Patients Using Ultrawide MRI

Vyvanse Evaluated for Weight Management in Children Aged 6-12

FDA Approval for Children's Advil-Flavored Supplement by Haleon

Study on Prone Position in Acute Bronchiolitis Aims to Reduce Ventilation Needs

GE HealthCare Issues Correction for Infant Resuscitation Systems Due to Oxygen Concentration Risk

Trial of SMS Platform to Prevent Malnutrition in HIV-Exposed Children in Kenya

Upcoming catalysts

Indications

Get signals before the market moves